Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-20-000216
Date:2020-01-02
Issuer: REGENXBIO INC. (RGNX)
Original Submission Date:

Reporting Person:

VASISTA VITTAL
C/O REGENXBIO INC.
9600 BLACKWELL ROAD, SUITE 210 ROCKVILLE, MD 20850

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 38.99 2020-01-02 deemed execution date A 50,000 (a) 2030-01-02 common stock 50,000 $38.99 50,000 direct
Footnotes
IDfootnote
f1 25% of the shares subject to this option shall vest after 12 months of continuous service with the issuer. the balance will vest in equal monthly installments over the 36 months following january 2, 2021 while the optionee provides continuous service to the issuer.
WhaleWisdom Logo

Elevate your investments